Abstract:Objective The investigation aimed at producing transgenic mouse model with myocardium-specific overex-pression of human KCNE4 (hKCNE4) gene so as to research into the prophylactic and therapeutic effect of hKCNE4 gene on a certain subset of atrial fibrillation. Methods hKCNE 4 gene was cloned by reverse transcription-polymerase chain reaction (RT-PCR), digested with restrictive endonuclease, and inserted into the cardiomyocyte-specific expressing plasmidα-MHC-Clone 26 by ligase. Enzymatic and sequencing analyses were performed to confirm hKCNE4-α-MHC-Clone 26 prior to obtaining the BamHI treated transgenic element hKCNE4-α-MHC-hGH pA. The hKCNE4-α-MHC-hGH pA was microinjected into the male pronucleus of fertilized oocyte of C57BL mice and the oocytes surviving microin-jection were transplanted into the oviducts of pseudo-pregnant mice. The positive transgenic founder (G0 generation) mice were identified by PCR from offspring generated by pseudo-pregnant mice. The G0 transgenic mice were mated respectively with wild-type C57BL mice to reproduce G1 transgenic progeny. RT-PCR and sequencing were applied to screening for transgenic mice expressing hKCNE4 from G1 transgenic descendants. Results hKCNE4 gene was cloned and ligated to the vectorα-MHC-Clone 26 correctly. 86 mice were generated 9 of which were identified to be transgenic and the trans-gene hKCNE 4 carried by 2 transgenic mice (titled as Line A and Line B respectively) was not only transmitted to the next generation but also overexpressed restrictedly in the hearts. Preliminary phenotypic analysis on the transgenic progeny of Line A and Line B showed that they developed normally, reproduced generally, and suffered from no arrhythmia documented by surface electrocardiography. Conclusion The results indicate that the transgenic mice cardiomyocyte-specifically overexpressing hKCNE 4 are successfully procured, which provides a valuable tool for the exploration of the preventive and remedial influence of hKCNE 4 on a subgroup of atrial fibrillation.

Establishment of BIGH3R555W-mutation transgenic mice

Establishment of a Transgenic Mouse Model of Corneal Dystrophy Overexpressing Human BIGH3.

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Arg555Trp mutation of BIGH3 gene inducing granular corneal dystrophy Groenouw type Ⅰ

Establishment of Mouse Model Highly Expressing Bcl-2 Protein

The Establishment and Verification of a Model Mice Express Enhanced Green Fluorescent Protein for Human Glioma Research

The New Mutation Mouse with Heritable Disease of Cornea Matrix Denaturalization and the Mapping of Mutation Gene

Establishment of Hamster- and Human-Prnp Transgenic Mice.

Establishment of acetylcholine-sensitive K+ channels gene-knockout mouse model

Progress in the study of molecular genetics of BIGH3 related corneal dystrophy

Animal Model for Heterologous Transplantation-Generating of Transgenic Mice That Expresses Hcd59 Cdna

Establishment of Α-Synuclein Transgenic Mouse Model of Parkinson's Disease

Establishment of Double-gene Transgenic Mouse Model for Hht and Hdaf Through SMGT

Production of Human CD59 Cdna Transgenic Founder Mice--an Animal Model for Xenotransplantation

Establishment of Transgenic Mice Carrying Gene Encoding Human Zinc Finger Protein 191

Effects of human BIGH3 cloning and expression on keratocytes adhesion and migration

Modeling a Cataract Disorder in Mice with Prime Editing.

Development of Transgenic Mouse Model Containing Xyle Target Gene

Establishment of red fluorescence protein transgenic mouse model

Construction and Identification of a Novel Mice Model of Microphthalmia

Cloning of HBx, Ras Gene and Preliminary Study on Establishing Transgenic Mice by Transfection of Spermatogonial Cells